中文名 | 1-甲基-4-(3-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)苯基)哌嗪 |
---|---|
英文名 | 1-methyl-4-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazine |
分子式 | C17H27BN2O2 |
---|---|
分子量 | 302.21900 |
精确质量 | 302.21700 |
PSA | 24.94000 |
LogP | 1.74050 |
储存条件 | 2-8°C, 惰性气体保存 |
~% 747413-18-9 |
文献:VERNALIS (CAMBRIDGE) LIMITED; CANCER RESEARCH TECHNOLOGY LTD; THE INSTITUTE OF CANCER RESEARCH Patent: WO2004/72051 A1, 2004 ; Location in patent: Page 56 ; |
~% 747413-18-9 |
文献:MERCK PATENT GMBH; EGGENWEILER, Hans-Michael; HOELZEMANN, Guenter; DORSCH, Dieter Patent: WO2013/117285 A1, 2013 ; Location in patent: Page/Page column 83; 84 ; |
~% 747413-18-9 |
文献:Incyte Corporation; Lu, Liang; He, Chunhong; Yao, Wenqing Patent: US2014/45814 A1, 2014 ; Location in patent: Paragraph 0391; 0392 ; |
~55% 747413-18-9 |
文献:Patel, Gautam; Karver, Caitlin E.; Behera, Ranjan; Guyett, Paul J.; Sullenberger, Catherine; Edwards, Peter; Roncal, Norma E.; Mensa-Wilmot, Kojo; Pollastri, Michael P. Journal of Medicinal Chemistry, 2013 , vol. 56, # 10 p. 3820 - 3832 |
上游产品 6 | |
---|---|
下游产品 0 |